Doussoulin A, Saiz JL, Rivas R, Blanton S

Language: Spanish
References: 35
Page: 3-13
PDF size: 257.14 Kb.

ABSTRACT

Introduction: Constraint-induced therapy (CIT) is a therapeutic strategy that has been show to improve the function of the upper limb affected by a stroke. Although an extensive body of literature supports the positive impact of CIT on neuroplasticity and the recovery of function, most research has evaluated an individual mode of delivery. However, evidence is limited for the application of CIT protocol in a group setting.
Objective: To determine the effectiveness of a modified version of CIT in a group setting as compared to individual, one-on-one basis on the quantity and quality of movement of the paretic upper limb.
Methods: Forty participants, 6-60 months post stroke, were randomized into either a group or individual application of CIT. The hemiparetic upper extremity quantity and quality of movement was evaluated using the self-reported, Motor Activity Log and each participant’s clinical record at baseline, pre-treatment and post-treatment.
Results: The data were analyzed through an analysis of variance with a mixed factorial design 2 x 2. Both groups tended to improve their scores between baseline and pre-treatment measurement, however, no significant effect was found between groups for this time period. Conversely, group differences were seen between pre and post treatment evaluations.
Conclusion: This clinical trial provides evidence supporting the application of CIT delivered in a group mode for 3 hours, to improve the performance of the paretic upper limb in daily activities. However the evidence is still limited in relation to this mode CIT version.

REFERENCES

1. Feigin V. Stroke in developing countries: can the epidemic be stopped and outcomes improved? The Lancet Neurology 2007;6:94-97.

2. http://www.minsal.cl. Guía Clínica Ataque Cerebrovascular Isquémico del Adulto. Ministerio de Salud-Republica de Chile. Nº37:2007.

3. Urton M, Kohia M, Davis J, Neill M. Systematic literature review of treatment interventions for upper extremity hemiparesis following stroke. Occup Ther Int 2007;14:11-27.

4. Morris D, Taub E, Mark V. Constraint-induced movement therapy: characterizing the intervention protocol. Eura Medicophys 2006;42:257-68.

5. Doussoulin A. Terapia de restricción inducida y su impacto en revertir el “no uso aprendido en neurorehabilitación. Rev Kinesiol 2011;30:14-19.

6. Bonaiuti D, Rebasti L, Sioli P. The constraint induced movement therapy: a systematic review of randomised controlled trials on the adult stroke patients. Eura Medicophys 2007;43:139-46.

7. Doussoulin A. Descripción de la terapia de restricción inducida: Aplicabilidad en el contexto clínico. Rev Mex Neuroci 2012;13:223-32.

8. Sterr A, Elbert T, Berthold I, Kölbel S, Rockstroh B, Taub E. Longer versus shorter daily constraintinduced movement therapy of chronic hemiparesis: an exploratory study. Arch Phys Med Rehabil 2002;83:1374-7.

9. Lin K, Wu C, Wei T, Lee C, Liu J. Effects of modified constraint-induced movement therapy on reachto- grasp movements and functional performance after chronic stroke: a randomized controlled study. Clin Rehabil 2007;21:1075-86.

10. Page S, Levine P, Leonard A. Modified constraint-induced therapy in acute stroke: a randomized controlled pilot study. Neurorehabil Neural Repair 2005;19:27-32.

11. Page S, Sisto S, Levine P. Modified constraint-induced therapy in chronic stroke. Am J Phys Med Rehabil 2002;81:870-5.

12. Page S, Sisto S, Levine P, McGrath R. Efficacy of modified constraint-induced movement therapy in chronic stroke: a single-blinded randomized controlled trial. Arch Phys Med Rehabil 2004;85:14-8.

13. Wu C, Lin K, Chen H, Chen I, Hong W. Effects of modified constraint-induced movement therapy on movement kinematics and daily function in patients with stroke: a kinematic study of motor control mechanisms. Neurorehabil Neural Repair 2007;21:460-6.

14. Leung D, Ng A, Fong K. Effect of small group treatment of the modified constraint induced movement therapy for clients with chronic stroke in a community setting. Hum Mov Sci 2009;28:798-808.

15. Lang C, Edwards D, Birkenmeier R, Dromerick A. Estimating minimal clinically important differences of upper-extremity measures early after stroke. Arch Phys Med Rehabil 2008;89:1693-700.

16. Wolf S, Winstein C, Miller J, Taub E, Uswatte G, Morris D, et al. Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. JAMA 2006;296:2095-104.

17. Wolf S, Blanton S, Baer H, Breshears J, Butler A. Repetitive task practice: a critical review of constraint-induced movement therapy in stroke. Neurologist 2002;8:325-38.

18. Wolf S. Revisiting constraint-induced movement therapy: are we too smitten with the mitten? Is all nonuse “learned”? and other quandaries. Phys Ther 2007;87:1212-23.

19. Taub E, Uswatte G, Mark V, Morris D. The learned nonuse phenomenon: implications for rehabilitation. Eura Medicophys 2006;42:241-56.

20. Birman-Deych E, Waterman A, Yan Y, Nilasena D, Radford M, Gage B. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care 2005;43:480-5.

21. Riedemann P. Clinimetría: Aspectos Generales sobre medición en enfermedades musculoesqueléticas. Revista Chilena de Reumatología 2001;17:173-78.

22. Agredo C, Bedoya, J. Validación Escala Modificada de Ashworth

23. http://www.efisioterapia.net/info/colaboradores.php. Cali, Colombia. efisioterapia. net, 2005.

24. Uswatte G, Taub E, Morris D, Vignolo M, McCulloch K. Reliability and validity of the upper-extremity Motor Activity Log-14 for measuring real-world arm use. Stroke 2005;36:2493-6.

25. van der Lee J, Beckerman H, Knol D, de Vet H, Bouter L. Clinimetric properties of the motor activity log for the assessment of arm use in hemiparetic patients. Stroke 2004;35:1410-4.

26. Doussoulin A, Rivas R. Validación y uso de las escalas Motor Activity Log y Action Research Arm como instrumentos para evaluar la función de la extremidad superior parética posterior a enfermedad cerebro vascular en clínica e investigación. Rev Mex Neuroci 2014;15:138-46.

27. Rijntjes M, Hobbeling V, Hamzei F, Dohse S, Ketels G, Liepert J, et al. Individual factors in constraintinduced movement therapy after stroke. Neurorehabil Neural Repair 2005;19:238-49.

28. Leung D, Ng A, & Fong K. Effect of small group treatment of the modified constraint induced movement therapy for clients with chronic stroke in a community setting. Hum Mov Sci 2009;28:798-808.

29. Wu C, Chen C, Tsai W, Lin K, Chou S. A randomized controlled trial of modified constraint-induced movement therapy for elderly stroke survivors: changes in motor impairment, daily functioning, and quality of life. Arch Phys Med Rehabil 2007;88:273-8.

30. Ro T, Noser E, Boake C, Johnson R, Gaber M, Speroni A, et al. Functional reorganization and recovery after constraint-induced movement therapy in subacute stroke: case reports. Neurocase 2006;12:50-60.

31. Stevenson T, Thalman L. A modified constraint-induced movement therapy regimen for individuals with upper extremity hemiplegia. Can J Occup Ther 2007;74:115-24.

32. McDowd JM, Filion DL, Pohl PS, Richards LG, Stiers W. Attentional abilities and functional outcomes following stroke. J Gerontol B Psychol Sci Soc Sci 2003;58:45-53.

33. Appelros P, Nydevik I, Viitanen M. Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year. Stroke 2003;34:122-6.

34. Taylor S. Health psychology. 8° ed. New York: McGraw Hill. 2011.

35. Boake C, Noser E, Ro T, Baraniuk S, Gaber M, Johnson R, et al. Constraint-induced movement therapy during early stroke rehabilitation. Neurorehabil Neural Repair 2007;21:14-24.